Sr One is a venture capital and private equity firm investing in biotechnology companies that is headquartered in Cambridge, Massachusetts and was founded in 1985 as the sub-organization of GlaxoSmithKline. Sr One has invested over $830 million invested in the biotechnology space.
Sr One invests in pre-clinical, clinical, and commercial stage biotechnology companies. Notable investments made by Sr One include: Atopix, Alios BioPharma, NuPathe, Concert Pharmaceuticals, Gotham Therapeutics, Illuminoss, TP Therapeutics, ProtAffin, CRISPR Therapeutics, Arcellx, Adheron Therapeutics, Pulmocide, Second Genome, Sumprus Biosciences, Propeller, VHsquared, Nimbus Therapeutics, AGTC, and Constellation Pharmaceuticals.
Nkarta Therapeutics is a biotechnology company using natural killer (NK) immune cells for cellular therapies.
A biopharmaceutical company dedicated to the development of novel therapeutics in the field of Epigenetics
ZappRx is a Cambridge, Massachusetts-based health information technology company.
Propeller Health is a Madison, Wisconsin-based company.
Bicycle Therapeutics is a Cambridge, Massachusetts-based company.
Pandion Therapeutics is a Cambridge, Massachusetts-based company.
Palleon Pharmaceuticals is a Waltham, Massachusetts-based company.
Macrolide Pharmaceuticals is a Watertown, Massachusetts-based company.
Joyce A Lonergan
Documentaries, videos and podcasts